540523-99-7

Basic information

• Product Name: 6-chloro-1-(diphenylmethyl)-1H-indole-2-carbaldehyde
• Synonyms: 6-chloro-1-(diphenylmethyl)-1H-indole-2-carbaldehyde
• CAS NO: 540523-99-7
• Molecular Weight: 345.828
• Mol File: 540523-99-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 6-chloro-1-(diphenylmethyl)-1H-indole-2-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 6-chloro-1-(diphenylmethyl)-1H-indole-2-carbaldehyde(540523-99-7)
• EPA Substance Registry System: 6-chloro-1-(diphenylmethyl)-1H-indole-2-carbaldehyde(540523-99-7)

Safety Data

• Hazardous Substances Data: 540523-99-7(Hazardous Substances Data)

Upstream product

• 53590-59-3 6-chloro-1H-indole-2-carbaldehyde 
• 776-74-9 Bromodiphenylmethane 
• 53590-58-2 (6-chloro-1H-indol-2-yl)methanol 
• 27034-51-1 ethyl 6-chloro-1H-indole-2-carboxylate 
• 89-59-8 4-chloro-2-nitrotoluene 
• 540523-98-6 3-(4-chloro-2-nitro-phenyl)-2-oxo-propionic acid ethyl ester 

Downstream Products

• 934285-82-2 6-chloro-1-(diphenylmethyl)-2-[(E)-2-nitrovinyl]-1H-indole 
• 540524-03-6 methyl 4-{2-[2-{2-[(benzylsulfonyl)amino]ethyl}-6-chloro-1-(diphenylmethyl)-1H-indol-3-yl]ethoxy}benzoate 
• 540524-02-5 N-{2-[6-chloro-1-(diphenylmethyl)-1H-indol-2-yl]ethyl}-1-phenylmethanesulfonamide 
• 540524-01-4 {2-[6-chloro-1-(diphenylmethyl)-1H-indol-2-yl]ethyl}amine 
• 540524-00-3 1-benzhydryl-6-chloro-2-(2-nitro-vinyl)-1H-indole 

Relevant articles and documents

Methods for the use of inhibitors of cytosolic phospholipase A2 in the treatment of thrombosis

This invention provides methods for the use of substituted indole compounds of the general formula: and pharmaceutically acceptable salt forms thereof. The invention provides methods for the use of the compounds in the treating or preventing thrombosis in a mammal, or preventing progression of symptoms of thrombosis.

Inhibitors of cytosolic phospholipase A2

This invention provides substituted indole compounds of the general formula: and pharmaceutically acceptable salt forms thereof, and methods for using the compounds as inhibitors of the activity of various phospholipase enzymes, particularly phospholipase A2 enzymes, and for the medical treatment, prevention and inhibition of pain and inflammation.